Rituxan/MabThera
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Rituxan/MabThera, covering 2016-04-21 to 2017-11-14. Get the full timeline:
Most recent: Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma